GlassScriptPhysician profile
Rohit Dhir
NPI 1619225299
$4,712.95
in general payments reported to CMS, 2019-2025
33 companies · $431 in 2025
The $431 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,181 · 2020: $424 · 2021: $520 · 2022: $214 · 2023: $753 · 2024: $191 · 2025: $431.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,375.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neotract INC. | $1,655.29 | 2019-2020 | |
| Boston Scientific Corporation | $502.31 | 2019-2023 | Spaceoar Vue System - 10ml, Spaceoar System |
| Astellas Pharma US INC | $384.97 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $352.95 | 2020-2025 | Prolaris |
| Coloplast Corp | $352.80 | 2023 | Titan |
| Teleflex LLC | $177.13 | 2021 | |
| Imperative Care, INC | $119.55 | 2025 | Prodigy Catheter, Symphony Catheter |
| Tolmar, INC. | $112.68 | 2024-2025 | Jatenzo, Eligard |
| Sumitomo Pharma America, INC. | $108.17 | 2023-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $102.17 | 2019-2025 | Xyosted |
| Procept Biorobotics Corporation | $90.56 | 2024-2025 | Aquabeam System |
| Convatec INC. | $79.61 | 2019-2020 | |
| Axonics, INC. | $71.90 | 2021-2023 | Axonics |
| Dendreon Pharmaceuticals LLC | $70.32 | 2020-2025 | Provenge |
| Janssen Pharmaceuticals, INC | $62.50 | 2020 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $57.87 | 2019-2021 | |
| 180 Medical, INC. | $51.31 | 2019-2024 | |
| Medtronic, INC. | $45.69 | 2021-2022 | |
| Amgen INC. | $40.85 | 2019-2021 | |
| Angiodynamics, INC. | $32.11 | 2023 | Alphavac |
| Pfizer INC. | $29.91 | 2019 | |
| Myovant Sciences INC. | $29.04 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $27.36 | 2022 | |
| Urovant Sciences INC | $21.09 | 2022 | |
| Acerus Pharmaceuticals Corporation | $20.74 | 2020 | |
| Bard Peripheral Vascular, INC. | $19.85 | 2024 | Venclose Maven Catheter |
| Rochester Medical Corporation | $18.36 | 2022 | |
| Abc Home Medical Supply, INC. | $17.47 | 2025 | |
| Hollister Incorporated | $17.39 | 2021 | |
| Travere Therapeutics, INC. | $16.20 | 2021 | |
| Acell, INC. | $12.69 | 2020 | |
| Tactile Systems Technology INC | $12.11 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rohit Dhir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.